AFP |
alpha-fetoprotein |
ANXA3 |
Annexin A3 |
ApoA-1 |
apolipoprotein A1 |
ASGPR |
asialoglycoprotein receptor |
CK |
cytokeratin |
CPS1 |
carbamoyl phosphate synthetase 1 |
CSCs |
cancer stem cells |
CTCs |
circulating tumor cells |
ctDNA |
circulating tumor DNA |
EMA |
epithelial membrane antigen |
EMT |
epithelial to mesenchymal transition |
EpCAM |
epithelial cell adhesion molecule |
FDA |
the US Food and Drug Administration |
GPC |
glypican-3; GS: glutamine synthase |
HBV |
hepatitis b virus |
HCC |
hepatocellular carcinoma |
Hep Par 1 |
hepatocyte paraffin-1 |
IGFBP1 |
insulin like growth factor binding protein 1 |
OS |
overall survival |
pERK |
phosphorylated ERK |
PFS |
progression-free survival |
ROC |
receiver operating characteristic |
RT-PCR |
reverse transcriptase polymerase chain reaction |
TACE |
transcatheter arterial chemoembolization |
TNM |
tumor-node-metastasis |
Treg |
regulatory T cells |